Bioburden control
Bioburden control
Roche’s $50B US Boost: Jobs and Growth Ahead!
BIOT
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
Revolutionizing Bioprocessing: Streamlining Quality Control
BIOT
📰 Biopharma companies prioritize bioburden control in continuous bioprocessing to ensure product quality. 🧪 Integrated testing expedites detection and eliminates errors. 👩🔬 User requirements aid in fault detection. 💡 Timely decision-making is crucial. 📊 Managing data and implementing a two-tiered control system are key challenges. 👉 New equipment and automation facilitate in-process bioburden testing.
